✦ LIBER ✦

A systems pathology model for predicting overall survival in patients with refractory, advanced non-small-cell lung cancer treated with gefitinib

✍ Scribed by Michael J. Donovan; Angeliki Kotsianti; Valentina Bayer-Zubek; David Verbel; Mikhail Teverovskiy; Carlos Cordon-Cardo; Jose Costa; F. Anthony Greco; John D. Hainsworth; Dinah V. Parums

Book ID: 116429982
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 583 KB
Volume: 45
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2009.02.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictive factors associated with prolo

Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib

✍ Satouchi, M; Negoro, S; Funada, Y; Urata, Y; Shimada, T; Yoshimura, S; Kotani, Y 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 123 KB

Serum tumor markers as predictors for su

Serum tumor markers as predictors for survival in advanced non-small cell lung cancer patients treated with gefitinib

✍ Chiu, Chao-Hua; Shih, Yu-Ning; Tsai, Chun-Ming; Liou, Jia-Ling; Chen, Yuh-Min; P 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 235 KB

Polymorphisms of EGFR predict clinical o

Polymorphisms of EGFR predict clinical outcome in advanced non-small-cell lung cancer patients treated with Gefitinib

✍ Ma, Fei; Sun, Tong; Shi, Yuankai; Yu, Dianke; Tan, Wen; Yang, Ming; Wu, Chen; Ch 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 547 KB

Long-term survival in three patients wit

Long-term survival in three patients with metastatic non-small cell lung cancer treated with gefitinib

✍ Nakatomi, Katsumi; Soda, Hiroshi; Kitazaki, Takeshi; Nakano, Hirofumi; Uchida, K 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Improvements of quality of life in patie

Improvements of quality of life in patients with advanced non-small cell lung cancer treated with gefitinib

✍ Yanmei Zou; Hua Xiong; Shiying Yu 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 76 KB

Risk factors for interstitial lung disea

Risk factors for interstitial lung disease and predictive factors for tumor response in patients with advanced non-small cell lung cancer treated with gefitinib

✍ Takano, Toshimi; Ohe, Yuichiro; Kusumoto, Masahiko; Tateishi, Ukihide; Yamamoto, 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 151 KB